Is AVTE or EQR a better dividend investment in 2026?

AVTE currently yields 74.63% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: AVTE offers higher current income.

What is the dividend yield difference between AVTE and EQR?

AVTE has a forward dividend yield of 74.63% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 69.90 percentage points.

Home › Compare › AVTE vs EQR

AVTE vs EQR: Dividend Comparison 2026

AVTE yields 74.63% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVTE wins by $1.26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVTE

● Live price

74.63%

Share price

$2.68

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.30M

Annual income

$358,033.82

Full AVTE calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — AVTE vs EQR

📍 AVTE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVTE	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVTE + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVTE pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVTE

Annual income on $10K today (after 15% tax)

$6,343.28/yr

After 10yr DRIP, annual income (after tax)

$304,328.75/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, AVTE beats the other by $301,082.08/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVTE + EQR for your $10,000?

AVTE: 50%EQR: 50%

100% EQR50/50100% AVTE

Portfolio after 10yr

$671.1K

Annual income

$180,926.71/yr

Blended yield

26.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

AVTE

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$13.00

+385.1% upside vs current

Range: $2.00 — $35.00

Altman Z

2.1

Piotroski

2/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVTE buys

EQR buys

No recent congressional trades found for AVTE or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVTEEQR

Forward yield	74.63% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$1.30M	$40.5K ✓
Annual income after 10y	$358,033.82 ✓	$3,819.61
Total dividends collected	$1.12M	$16.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Hold	Hold
Analyst price target	$13.00	$70.35 ✓

Year-by-year: AVTE vs EQR ($10,000, DRIP)

Year	AVTE Portfolio	AVTE Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$18,163	$7,462.69	$11,248	$547.57	+$6.9K → AVTE
2	$32,102	$12,667.52	$12,701	$666.53	+$19.4K → AVTE
3	$55,273	$20,924.46	$14,405	$814.59	+$40.9K → AVTE
4	$92,813	$33,671.17	$16,413	$999.84	+$76.4K → AVTE
5	$152,151	$52,841.00	$18,795	$1,232.92	+$133.4K → AVTE
6	$243,759	$80,956.60	$21,639	$1,527.95	+$222.1K → AVTE
7	$382,036	$121,213.91	$25,057	$1,903.80	+$357.0K → AVTE
8	$586,325	$177,546.69	$29,197	$2,385.87	+$557.1K → AVTE
9	$882,029	$254,661.46	$34,250	$3,008.70	+$847.8K → AVTE
10	$1,301,805	$358,033.82	$40,467	$3,819.61	+$1.26M → AVTE

AVTE vs EQR: Complete Analysis 2026

AVTE — Stock

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Full AVTE Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this AVTE vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVTE vs SCHD AVTE vs JEPI AVTE vs O AVTE vs KO AVTE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.